Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

Addiction

Volumn 113, Issue 10, 2018, Pages 1905-1926

  Peacock, Amy ^a,b   Leung, Janni ^a,c,n,o   Larney, Sarah ^a,d   Colledge, Samantha ^a   Hickman, Matthew ^e   Rehm, Jürgen ^f,g,h   Giovino, Gary A ⁱ   West, Robert ^j   Hall, Wayne ^c,k   Griffiths, Paul ^l   Ali, Robert ^m   Gowing, Linda ^m   Marsden, John ^k   Ferrari, Alize J ^c,n,o   Grebely, Jason ^p   Farrell, Michael ^a   Degenhardt, Louisa ^a,n,q,r  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d BROWN UNIVERSITY   (United States)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h Institute of Clinical Psychology and Psychotherapy   (Germany)

ⁱ UNIVERSITY AT BUFFALO   (United States)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k KING'S COLLEGE LONDON   (United Kingdom)

^l European Monitoring Center for Drugs and Drug Addiction   (Portugal)

^m UNIVERSITY OF ADELAIDE   (Australia)

ⁿ UNIVERSITY OF WASHINGTON   (United States)

^o Queensland Centre for Mental Health Research   (Australia)

^p UNIVERSITY OF NEW SOUTH WALES   (Australia)

^q UNIVERSITY OF MELBOURNE   (Australia)

^r MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

more..

Author keywords

Alcohol; amphetamine; cannabis; cocaine; epidemiology; mortality; opioid; prevalence; substance dependence; tobacco

Indexed keywords

ALCOHOLISM; DRINKING BEHAVIOR; DRUG DEPENDENCE; GLOBAL DISEASE BURDEN; GLOBAL HEALTH; HUMAN; MORTALITY; PREVALENCE; SMOKING; TOBACCO USE; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

ALCOHOL DRINKING; ALCOHOLISM; GLOBAL BURDEN OF DISEASE; GLOBAL HEALTH; HUMANS; MORTALITY; PREVALENCE; SUBSTANCE-RELATED DISORDERS; TOBACCO SMOKING; TOBACCO USE; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

EID: 85052595028     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.14234     Document Type: Review

References (44)

1. Lim S. S., Vos T., Flaxman A. D., Danaei G., Shibuya K., Adair-Rohani H. et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224–2260
2. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373: 2223–2233
3. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55–70
4. United Nations General Assembly. Transforming Our World: the 2030 Agenda for Sustainable Development. Geneva: United Nations; 2015
5. Gowing L. R., Ali R. L., Allsop S., Marsden J., Turf E. E., West R. et al. Global statistics on addictive behaviours: 2014 status report. Addiction 2015; 110: 904–919
6. Hall W., Weier M. Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clin Pharmacol Ther 2015; 97: 607–615
7. Larance B., Degenhardt L., Lintzeris N., Winstock A., Mattick R. Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev 2011; 30: 236–245
8. Abdul-Quader A. S., Baughman A. L., Hladik W. Estimating the size of key populations: current status and future possibilities. Curr Opin HIV AIDS 2014; 9: 107–114
9. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Responding to New Psychoactive Substances. Lisbon: EMCDDA; 2011
10. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2017. Vienna: UNODC; 2017
11. European School Survey Project on Alcohol and Other Drugs (ESPAD) Group. ESPAD Report 2015: Results from the European School Survey Project on Alcohol and Other Drugs. Luxembourg: Publications Office of the European Union; 2016
12. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2017: Trends and Developments. Luxembourg: Publications Office of the European Union; 2017
13. Van Buskirk J., Griffiths P., Farrell M., Degenhardt L. Trends in new psychoactive substances from surface and ‘dark’ net monitoring. Lancet Psychiatry 2017; 4: 16–18
14. World Health Organization (WHO). Global Information System on Alcohol and Health (GISAH). Geneva: WHO; 2016
15. Institute for Health Metrics and Evaluation. GBD Results Tool. Seattle, WA: IHME, University of Washington; 2016
16. Degenhardt L., Peacock A., Colledge S., Leung J., Grebely J., Vickerman P. et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health 2017; 5: e1192–e1207
17. West R., McEwen A., Bolling K., Owen L. Smoking cessation and smoking patterns in the general population: a 1-year follow-up. Addiction 2001; 96: 891–902
18. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Washington DC: APA; 2000
19. World Health Organization (WHO). The ICD-10 Classification of Mental and Behavioural Disorders—Diagnostic Criteria for Research. Geneva: WHO; 1993
20. Kassebaum N. J., Arora M., Barber R. M., Bhutta Z. A., Brown J., Carter A. et al. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1603–1658
21. US Department of Health and Human Services. The Health Consequences of Smoking. 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014
22. Larney S., Peacock A., Leung J., Colledge S., Hickman M., Vickerman P. et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Health 2017; 5: e1208–e1220
23. Flaxman A. D., Vos T., Murray C. J. An Integrative Metaregression Framework for Descriptive Epidemiology. Seattle: University of Washington Press; 2015
24. Gmel G., Rehm J. Measuring alcohol consumption. Contemp Drug Probl 2004; 31: 467
25. Rehm J., Kehoe T., Gmel G., Stinson F., Grant B., Gmel G. Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example. Popul Health Metrics 2010; 8: 3
26. Rehm J., Kailasapillai S., Larsen E., Rehm M. X., Samokhvalov A. V. Shield K. D., et al. A systematic review of the epidemiology of unrecorded alcohol consumption and the chemical composition of unrecorded alcohol. Addiction 2014; 109: 880–893
27. GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet 2017; 389: 1885–1906
28. Giovino G. A., Mirza S. A., Samet J. M., Gupta P. C., Jarvis M. J., Bhala N. et al. Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012; 380: 668–679
29. Joint United Nations Programme on HIV/AIDS. 90-90-90: An Ambitious Treatment Target to Help End the AIDS Epidemic. Geneva: UNAIDS; 2014
30. Jones H. E., Hickman M., Welton N. J., De Angelis D., Harris R. J., Ades A. Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources. Am J Epidemiol 2014; 179: 1383–1393
31. Wesson P., Reingold A., McFarland W. Theoretical and empirical comparisons of methods to estimate the size of hard-to-reach populations: a systematic review. AIDS Behav 2017; 21: 2188–2206
32. Hickman M., De Angelis D., Jones H., Harris R., Welton N., Ades A. Multiple parameter evidence synthesis—a potential solution for when information on drug use and harm is in conflict. Addiction 2013; 108: 1529–1531
33. Institute for Health Metrics and Evaluation (IHME). A Protocol for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Seattle, WA: IHME; 2015
34. Barendregt J. J., Van Oortmarssen G. J., Vos T., Murray C. J. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Popul Health Metrics 2003; 1: 4
35. United Nations Office on Drugs and Crime (UNODC). Methodology—World Drug Report 2017. Vienna: UNODC; 2017
36. Murray C. J. L., Ezzati M., Lopez A. D., Rodgers A., Vander Hoorn S. Comparative quantification of health risks: conceptual framework and methodological issues. In: Ezzati M., Lopez A. D., Rodgers A., Murray C. J. L., editors. Comparative Quantification of Health Risks: Global and regional Burden of Disease attributable to selected major risk factors. Geneva, Switzerland: World Health Organization; 2004, pp. 1–38
37. Rehm J., Gmel G. E., Gmel G., Hasan O. S., Imtiaz S., Popova S. et al. The relationship between different dimensions of alcohol use and the burden of disease—an update. Addiction 2017; 112: 968–1001
38. Ruhm C. J. Corrected US opioid-involved drug poisoning deaths and mortality rates, 1999–2015. Addiction 2018; https://doi.org/10.1111/add.14144
39. de Savigny D., Riley I., Chandramohan D., Odhiambo F., Nichols E., Notzon S. et al. Integrating community-based verbal autopsy into civil registration and vital statistics (CRVS): system-level considerations. Glob Health Action 2017; 10; 1272882
40. Feigin V. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459–1544
41. Gravely S., Giovino G. A., Craig L., Commar A., D'Espaignet E. T., Schotte K. et al. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. Lancet Public Health 2017; 2: e166–e174
42. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention: Tobacco Control. Volume 12. Methods for Evaluating Tobacco Control Policies. Lyon, France: International Agency for Research on Cancer; 2008
43. Lai F. Y., Bruno R., Hall W., Gartner C., Ort C., Kirkbride P. et al. Profiles of illicit drug use during annual key holiday and control periods in Australia: wastewater analysis in an urban, a semi-rural and a vacation area. Addiction 2013; 108: 556–565
44. Ort C., Nuijs A. L., Berset J. D., Bijlsma L., Castiglioni S., Covaci A. et al. Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis. Addiction 2014; 109: 1338–1352